Trials / Withdrawn
WithdrawnNCT00762801
Studies on the Expression and Functions of RLIP76 in Blood Samples of Healthy Human Subjects
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- University of North Texas Health Science Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
RLIP76 (Ral binding protein1) is a 76 kDa splice variant protein encoded by the human gene (RALBP1, 18p11.22). It is a multifunctional modular protein found ubiquitously from Drosophila to humans, in cells ranging from red blood cells to endothelial cells of the brain. Its expression more predominant in breast, heart, liver and less so in colon and brain parenchyma.
Detailed description
RLIP76 is shown to be over expressed in a variety of cancer cells. However, no study has yet been done on its expression on normal cells. The studies proposed in this project will study the expression of RLIP76 in blood cells of healthy human subjects in the population of North Texas region.
Conditions
Timeline
- Start date
- 2008-09-01
- Primary completion
- 2011-09-01
- Completion
- 2011-09-01
- First posted
- 2008-09-30
- Last updated
- 2016-10-26
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00762801. Inclusion in this directory is not an endorsement.